Ounce of prevention
11 August 2020

Drugmakers like AstraZeneca and Pfizer may soon get regulators’ blessing for coronavirus inoculations. Yet doubts will linger over the treatments’ efficacy and profitability, and manufacturing delays mean poor countries will have to wait. Breakingviews explains why.